Tributary Capital Management, LLC 10x Genomics, Inc. Transaction History

Tributary Capital Management, LLC

  • $1.29 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 22, 2022
SELL
$55.7 - $145.79 $401,040 - $1.05 Million
-7,200 Closed
0 $0
Q4 2021

Jan 06, 2022
BUY
$135.05 - $182.59 $202,575 - $273,885
1,500 Added 26.32%
7,200 $1.07 Million
Q3 2021

Oct 14, 2021
BUY
$145.58 - $192.14 $829,806 - $1.1 Million
5,700 New
5,700 $830,000

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Tributary Capital Management, LLC Portfolio

Follow Tributary Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email